1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Infecciosas

Enfermedades Infecciosas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Palacios-Baena ZR, Gutiérrez-Gutiérrez B, De Cueto M, Viale P, Venditti M, Hernández-Torres A, Oliver A, Martínez-Martínez L, Calbo E, Pintado V, Gasch O, Almirante B, Antonio Lepe J, Pitout J, Akova M, Peña-Miralles C, Schwaber MJ, Tumbarello M, Tacconelli E, Origüen J, Prim N, Bou G, Giamarellou H, Bermejo J, Hamprecht A, Pérez F, Almela M, Lowman W, Hsueh PR, Navarro-San Francisco C, Torre-Cisneros J, Carmeli Y, Bonomo RA, Paterson DL, Pascual Á, Rodríguez-Baño J, REIPI/ESGBIS/INCREMENT Group.

    Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-ß-lactamase-producing Enterobacteriaceae.

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 72(3): 906-913. Nº de citas: 63

    [doi:10.1093/jac/dkw513]

  • Morillo CA, Waskin H, Sosa-Estani S, Del Carmen Bangher M, Cuneo C, Milesi R, Mallagray M, Apt W, Beloscar J, Gascon J, Molina I, Echeverria LE, Colombo H, Perez-Molina JA, Wyss F, Meeks B, Bonilla LR, Gao P, Wei B, McCarthy M, Yusuf S, STOP-CHAGAS Investigators.

    Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers: The STOP-CHAGAS Trial.

    JACC-Journal of the American College of Cardiology . 69(8): 939-947. Nº de citas: 266

    [doi:10.1016/j.jacc.2016.12.023]

  • Serrano-Villar S, Vásquez-Domínguez E, Pérez-Molina JA, Sainz T, de Benito A, Latorre A, Moya A, Gosalbes MJ, Moreno S.

    HIV, HPV, and microbiota: partners in crime?

    AIDS . 31(4): 591-594. Nº de citas: 27

    [doi:10.1097/QAD.0000000000001352]

  • Temkin E, Torre-Cisneros J, Beovic B, Benito N, Giannella M, Gilarranz R, Jeremiah C, Loeches B, Machuca I, Jiménez-Martín MJ, Martínez JA, Mora-Rillo M, Navas E, Osthoff M, Pozo JC, Ramos Ramos JC, Rodriguez M, Sánchez-García M, Viale P, Wolff M, Carmeli Y.

    Ceftazidime-Avibactam as Salvage Therapy for Infections Caused by Carbapenem-Resistant Organisms.

    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY . 61(2): . Nº de citas: 165

    [doi:10.1128/AAC.01964-16]

  • Fortun J, Modi YS, Bessette A, Heffez J, Carvounis P, Petkovsek DS, Anderson NG, Martin D, Srivastava S.

    Clinical Features and Management of Subretinal Abscesses Secondary to Methicillin-Resistant Staphylococcus aureus Endogenous Endophthalmitis.

    Ophthalmic Surgery Lasers & Imaging Retina . 48(2): 134-142. Nº de citas: 6

    [doi:10.3928/23258160-20170130-07]

  • Ponce-Alonso M, Del Campo R, Fortun J, Canton R, Morosini MI.

    First description of late recurrence of catheter-associated bacteraemia due to Cellulosimicrobium cellulans.

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 35(2): 131-133. Nº de citas: 4

    [doi:10.1016/j.eimc.2016.05.003]

  • Rivero A, Pérez-Molina JA, Blasco AJ, Arribas JR, Crespo M, Domingo P, Estrada V, Iribarren JA, Knobel H, Lázaro P, López-Aldeguer J, Lozano F, Moreno S, Palacios R, Pineda JA, Pulido F, Rubio R, de la Torre J, Tuset M, Gatell JM.

    Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 35(2): 88-99. Nº de citas: 6

    [doi:10.1016/j.eimc.2016.06.013]

  • Gudiol C, Royo-Cebrecos C, Tebe C, Abdala E, Akova M, Álvarez R, Maestro-de la Calle G, Cano A, Cervera C, Clemente WT, Martín-Dávila P, Freifeld A, Gómez L, Gottlieb T, Gurguí M, Herrera F, Manzur A, Maschmeyer G, Meije Y, Montejo M, Peghin M, Rodríguez-Baño J, Ruiz-Camps I, Sukiennik TC, Carratalà J, BICAR study group.

    Clinical efficacy of ß-lactam/ß-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum ß-lactamase-producing Enterobacteriaceae in haematological patients with neutropaenia: a study protocol for a retrospective observational study (BICAR).

    BMJ Open . 7(1): . Nº de citas: 8

    [doi:10.1136/bmjopen-2016-013268]

  • Neumayr A, Muñoz J, Schunk M, Bottieau E, Cramer J, Calleri G, López-Vélez R, Angheben A, Zoller T, Visser L, Serre-Delcor N, Genton B, Castelli F, Van Esbroeck M, Matteelli A, Rochat L, Sulleiro E, Kurth F, Gobbi F, Norman F, Torta I, Clerinx J, Poluda D, Martinez M, Calvo-Cano A, Sanchez-Seco MP, Wilder-Smith A, Hatz C, Franco L, for TropNet.

    Sentinel surveillance of imported dengue via travellers to Europe 2012 to 2014: TropNet data from the DengueTools Research Initiative.

    Eurosurveillance . 22(1): . Nº de citas: 39

    [doi:10.2807/1560-7917.ES.2017.22.1.30433]

  • Perez-Molina JA, Rubio R, Rivero A, Pasquau J, Suárez-Lozano I, Riera M, Estébanez M, Palacios R, Sanz-Moreno J, Troya J, Mariño A, Antela A, Navarro J, Esteban H, Moreno S.

    Simplification to dual therapy (atazanavir/ritonavir + lamivudine) versus standard triple therapy [atazanavir/ritonavir + two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study).

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 72(1): 246-253. Nº de citas: 57

    [doi:10.1093/jac/dkw379]

  • Serrano-Villar S, Zhou Y, Rodgers AJ, Moreno S.

    Different impact of raltegravir versus efavirenz on CD4/CD8 ratio recovery in HIV-infected patients.

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 72(1): 235-239. Nº de citas: 30

    [doi:10.1093/jac/dkw375]

  • Aldámiz-Echevarría Lois T, López-Polín A, Norman FF, Monge-Maillo B, López-Vélez R, Perez-Molina JA.

    Delayed haemolysis secondary to treatment of severe malaria with intravenous artesunate: Report on the experience of a referral centre for tropical infections in Spain.

    Travel Medicine and Infectious Disease . 15: 52-56. Nº de citas: 17

    [doi:10.1016/j.tmaid.2016.10.013]

  • Rueda C, Puig-Asensio M, Guinea J, Almirante B, Cuenca-Estrella M, Zaragoza O.

    Evaluation of the possible influence of trailing and paradoxical effects on the clinical outcome of patients with candidemia.

    CLINICAL MICROBIOLOGY AND INFECTION . 23(1): . Nº de citas: 50

    [doi:10.1016/j.cmi.2016.09.016]

  • Saumoy M, Llibre JM, Terrón A, Knobel H, Arribas J, Domingo P, Arroyo-Manzano D, Rivero A, Moreno S, Podzamczer D.

    Short Communication: Maraviroc Once-Daily: Experience in Routine Clinical Practice.

    AIDS RESEARCH AND HUMAN RETROVIRUSES . 33(1): 29-32. Nº de citas: 4

    [doi:10.1089/AID.2015.0386]

  • Aronson N, Herwaldt BL, Libman M, Pearson R, Lopez-Velez R, Weina P, Carvalho EM, Ephros M, Jeronimo S, Magill A.

    Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).

    CLINICAL INFECTIOUS DISEASES . 63(12): 202-264. Nº de citas: 366

    [doi:10.1093/cid/ciw670]

  • Vallejo A, Monge-Maillo B, Gutiérrez C, Norman FF, López-Vélez R, Pérez-Molina JA.

    Changes in the immune response after treatment with benznidazole versus no treatment in patients with chronic indeterminate Chagas disease.

    ACTA TROPICA . 164: 117-124. Nº de citas: 34

    [doi:10.1016/j.actatropica.2016.09.010]

  • García-Fernández S, Morosini MI, Cobo M, Foruny JR, López-Sanromán A, Cobo J, Romero J, Cantón R, Del Campo R.

    Gut eradication of VIM-1 producing ST9 Klebsiella oxytoca after fecal microbiota transplantation for diarrhea caused by a Clostridium difficile hypervirulent R027 strain.

    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE . 86(4): 470-471. Nº de citas: 20

    [doi:10.1016/j.diagmicrobio.2016.09.004]

  • Cain LE, Saag MS, Petersen M, May MT, Ingle SM, Logan R, Robins JM, Abgrall S, Shepherd BE, Deeks SG, Gill MJ, Touloumi G, Vourli G, Dabis F, Vandenhende MA, Reiss P, van Sighem A, Samji H, Hogg RS, Rybniker J, Sabin CA, Jose S, Del Amo J, Moreno S, Rodríguez B, Cozzi-Lepri A, Boswell SL, Stephan C, Pérez-Hoyos S, Jarrin I, Guest JL, Monforte AD, Antinori A, Moore R, Campbell CN, Casabona J, Meyer L, Seng R, Phillips AN, Bucher HC, Egger M, Mugavero MJ, Haubrich R, Geng EH, Olson A, Eron JJ, Napravnik S, Kitahata MM, Van Rompaey SE, Teira R, Justice AC, Tate JP, Costagliola D, Sterne JA, Hernán MA, Antiretroviral Therapy Cohort Collaboration, the Centers for AIDS Research Netwo.

    Using observational data to emulate a randomized trial of dynamic treatment-switching strategies: an application to antiretroviral therapy.

    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY . 45(6): 2038-2049. Nº de citas: 52

    [doi:10.1093/ije/dyv295]